Feature Channels:

AIDS and HIV

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Science

Channels:

Nanomedicine, Hiv Prevention, Truvada, nanochannels, Drug Delivery, space nanomedicine

Houston Methodist Receives Award for Implantable HIV Drug Delivery Device

nDSprototype.jpg

The Houston Methodist Research Institute’s department of nanomedicine is the recipient of this year’s AIDS Foundation Houston Shelby Hodge Vision Award. Alessandro Grattoni, Ph.D., nanomedicine department chair at the Houston Methodist Research Institute, accepted the award during the World AIDS Day luncheon.

Medicine

Channels:

Today Is World AIDS Day. Find the Latest Resources and Experts on the AIDS Epidemic in the AIDS and HIV News Source

Today is World AIDS Day. Find the latest resources and experts on the AIDS epidemic in the AIDS and HIV News Source

Science

Channels:

Methadone Treatment, Methadone, drug abuse treatment, Johns Hopkins Carey Business School, African American

Lower-Than-Recommended Methadone Doses for Opiate Addiction Are More Likely at Facilities Managed by African-American Directors, Johns Hopkins Study Shows

While the daily dose of methadone for opiate addiction has declined in recent years, facilities run by African-American directors were more likely to provide low methadone doses than facilities run by managers of other races and ethnicities.

Medicine

Channels:

Infectious Diseases, 1917 clinic, Center for AIDS Research, Cfar, World Aids Day, AIDS Clinical Trials Group, HIV, HIVAIDS, Hiv Aids, AIDS, Global

UAB Celebrates World AIDS Day 2016 and 30 Years of Research in the Clinical Trials Network

michael_saag_aids_day.jpg

Three decades of clinical trials have changed the face of HIV/AIDS.

Medicine

Channels:

AIDS, World Aids Day, TB and HIV, Tuberculosis, Pulmonary and Respiratory Medicine, HIV and AIDS, TB infection

Global Response to Fight AIDS Urgently Needed This World AIDS Day, Dec. 1: Forum of International Respiratory Societies

HIV-TBWorldAIDSDay2016.jpg

In recognition of World AIDS Day, held annually on Dec. 1 each year since 1988, the Forum of International Respiratory Societies (FIRS) is calling on governments, health advocates and non-government organizations to strengthen their response to HIV/AIDS. In 2015 AIDS claimed 1.1 million lives.

Life

Social and Behavioral Sciences

Channels:

World, People, HIV

Psychologists Available to Discuss World AIDS Day

Medicine

Channels:

University of Pennsylvania School of Nursing, Penn Nursing Science, Penn Nursing, Anne Teitelman, HIV, HIVAIDS, H, PREP

Penn Nursing and New York Blood Center Receive NIMH Grant to Create HIV Prevention Program for Women

Anne_Teitelman_2016.jpg

The University of Pennsylvania School of Nursing and the New York Blood Center, in partnership with local community consulting groups, have received a $769,578 grant from the National Institute of Mental Health to embark on designing an awareness program on the usage of the daily oral medication Pre-Exposure Prophylaxis (PrEP).

Medicine

Channels:

HIV, Hiv 1, AIDS, Immune System, Vaccine, Hiv Vaccine, Virology, World Aids Day, Sexually Transmitted Disease, Sexually Transmitted Infections, Sex

Frontline Attack Against HIV Infection Is Closer to Reality

Eric-Gowans-Lab-low-res-07.jpg

Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.

Medicine

Channels:

HIV, AIDS, AIDS Clinical Trials Unit, PLoS Pathogens, Translational Research

Genetically Engineered T Cells Render HIV’s Harpoon Powerless

When HIV attacks a T cell, it attaches itself to the cell’s surface and launches a “harpoon” to create an opening to enter and infect the cells. To stop the invasion, researchers from the Penn Center for AIDS Research at the University of Pennsylvania and scientists from Sangamo BioSciences, Inc. have developed genetically engineered T cells armed with a so-called “fusion inhibitor” to disrupt this critical step and prevent a wide range of HIV viruses from entering and infecting the T cells. The findings were reported today online in a preclinical study in PLOS Pathogens.

Medicine

Channels:

HIV, AIDS, Hiv Aids, HIV and AIDS, Center for AIDS Research, Global Health

International HIV Symposium Comes to Birmingham

AIDS_Awareness_Ribbon_ts.jpg

Scientists from around the world will gather at UAB in December to focus on HIV research and women, particularly collaborative research on women living with HIV and those at risk.

Life

Social and Behavioral Sciences

Channels:

drug war, Drug Policy, HIV, African Americans, Stigma and Health, incarcerated men

Public Health Researchers Examine How Drug Policy Impacts HIV Vulnerability Among African Americans

DrugWarModelForJulie.jpg

Researchers at the University of Louisville School of Public Health and Information Sciences have developed a tool for framing the relationship between policy, criminal justice practices and HIV-related factors that impact racial disparities.

Medicine

Channels:

GW School of Medicine and Health Sciences, GW Cancer Center, HIVAIDS, NCI, National Cancer Insitute, HIV and Cancer, HIV, Retroviruses, Cancer Research, Cancer, Hiv Research, DNA, Genetics

GW Researchers Receive $2.2M Grant to Study HERV Expression in Cancer

GW researchers received a $2.2 million grant from the National Cancer Institute to uncover why certain cancer types increase whereas others are unchanged or even decrease in those with HIV infection.

Medicine

Channels:

HIV, Human Immunodeficiency Virus, AIDS, infected cells, Vaccine, Immune System, DNA, simian immunodeficiency virus, SIV, Antiretroviral Therapy

New Therapeutic Vaccine Approach Holds Promise for HIV Remission

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR), Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV. In animal trials, the combination decreased levels of viral DNA in peripheral blood and lymph nodes, and improved viral suppression and delayed viral rebound following discontinuation of anti-retroviral therapy (ART). The research team’s findings appeared online today in the journal Nature.

Medicine

Channels:

HIV, AIDS, Clincal Trial, New England Journal Of Medicine

New Research Shows Promise for Immunotherapy as HIV Treatment

Immunotherapy has revolutionized treatment options in oncology, neurology, and many infectious diseases and now there is fresh hope that the same method could be used to treat or even functionally cure HIV, according to two related studies from Perelman School of Medicine at the University of Pennsylvania, the University of Alabama at Birmingham (UAB), and the National Institutes of Health (NIH).

Medicine

Channels:

Infectious Diseases, AIDS, HIV, Hiv 1, HIV antibodies, VRC01, Clinical Trial

Antibody Supresses HIV in Infected Individuals

209701996867378.gE3mskl6ldnH9Z5vtg74_height640.png

Antibody VRC01 proves safe for individuals infected with HIV-1 but only modestly controls the virus in participants who stop receiving antiretroviral therapy.

Medicine

Life

Law and Public Policy

Channels:

Medicines, essential medicines, universal health coverage, Universal Health Care, low-income countries, middle-income countries, World Health Organization, HIV, AIDS, Diabetes, Cardiovascular Diseases, Mental Health Disorders, respiratory conditions, national health systems

Funding a Set of Essential Medicines for Low- and Middle-Income Countries

CorrinaMoucheraud.jpg

As the world moves toward universal health coverage, the question arises: How can governments ensure equitable access to essential medicines in low- and middle-income countries? A section of The Lancet Commission on Essential Medicines Policies report, released today, finds that funding for a “basket” of these essential medicines may pose a challenge, but not necessarily an insurmountable one, for the global health community.

Medicine

Science

Channels:

DNA mutagenesis, genetic variants, DNA library

New Technique May Speed Search for Genetic Roots of Disease

DNASeqIllustration2.jpg

A new technique to cheaply and rapidly create sets of DNA fragments that include all possible genetic variants will help scientists distinguish between genetic variants linked to disease and those that are innocuous.

Medicine

Channels:

HIV, Nephropathy, Kidney Disease

Researchers Identify Receptor That May Allow HIV to Infect Kidney Cells

• New research suggests that transmembrane TNF-alpha may allow HIV to infect kidney cells that not express the major HIV-1 CD4 receptor. The findings could provide insights on how patients develop HIV-1 associated nephropathy.

Medicine

Channels:

How AIDS Conquered North America

125485_web.jpg

Researchers were able to restore HIV genomes from serum samples more than 40 years old, enabling them to reconstruct the origins of the AIDS pandemic in unprecedented detail

Medicine

Channels:

New Insight on Cytomegalovirus Infection, Breakthrough Therapy for Patients with Giant Cell Arteritis, Zika Infection May Affect Adult Brain Cells and More in the Cell Biology News Source

The Latest in Cell Biology News







Chat now!